Sphere-linked immunodiagnostic assay (SLIDA): an electron microscopic method for detecting specific antibodies. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Sphere-linked immunodiagnostic assay (SLIDA): an electron microscopic method for detecting specific antibodies.

Biotechniques. 1990 Sep;9(3):342-50. Unique Identifier : AIDSLINE MED/91026022
Hari V; Baunoch D; Das P; Wayne State University, Detroit, MI 48202.


Abstract: We have developed a sensitive method, sphere-linked immunodiagnostic assay, using specific antigens covalently bonded to microspheres for the detection of antibodies in serum. In this method, specific antigens, such as the capsid proteins of tobacco mosaic virus and tobacco etch virus, were independently, covalently bonded to plastic micropheres of 0.5 microns or 0.9 microns in diameter. The antigen-linked spheres were then exposed to normal serum or serum containing specific antibody, followed by treatment with gold-labeled secondary antibodies. The binding of the gold-labeled secondary antibodies to the specific primary antibodies on the spheres acted as an indication of the presence of the specific primary antibodies. The spheres were then examined and photographed by transmission electron microscopy. The number of gold particles bound to the spheres was counted manually using the photographs. The gold labeling was found to be specific and sensitive, enabling detection of antibodies present in highly diluted antisera. The efficiency and sensitivity of the technique for detection of antibodies were compared with those of the enzyme-linked immunosorbent assay and found to be highly sensitive. The technique was also used for testing for the presence of antibodies to herpes simplex virus as well as antibodies to Staphylococcus enterotoxin using microspheres coated with the respective antigens. We believe that this technique could be applied clinically when needed for detection of antibodies to other viruses, such as the Human Immunodeficiency Virus.
Keywords: Antibodies/*BLOOD Antibodies, Bacterial/BLOOD Antibodies, Viral/BLOOD Antibody Specificity Biotechnology Comparative Study Enzyme-Linked Immunosorbent Assay Human Immunohistochemistry Immunologic Tests/*METHODS Microscopy, Electron Microspheres Support, Non-U.S. Gov't JOURNAL ARTICLEKWDantibodies/KWDbloodantibodies,bacterial/bloodantibodies,viral/bloodantibodyspecificitybiotechnologycomparativestudyenzyme-linkedimmunosorbentassayhumanimmunohistochemistryimmunologictests/KWDmethodsmicroscopy,electronmicrospheressupport,non-uKWDsKWDgov'tjournalarticle
910228
M9120689

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .